Direktorat Registrasi ObatValid

ENSPRYNG

Claim this product
BPOM Number
DKI2157508743A1
Approved
21 November 2024
Expiry
20 December 2026
Form
INJEKSI; 120 MG

About This Registration

ENSPRYNG is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2157508743A1. Its current registration status is Valid, with the licence valid until 20 December 2026. The product is registered to MENARINI INDRIA LABORATORIES - INDONESIA. BPOM first approved this registration in December 2021. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 1 PREFILLED SYRINGE @ 120 MG/ 1 ML
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

SATRALIZUMAB

Market Intelligence

Owner Portfolio
MENARINI INDRIA LABORATORIES - INDONESIA holds 98 BPOM registrations
Manufacturer Scale
MENARINI INDRIA LABORATORIES - INDONESIA produces 98 registered products
Registration Age
Registered for 4 years, 9 months
Expiry Status
Expires in 84 days

FDA Cross-Reference

via openFDA
Generic Name
SATRALIZUMAB
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
SUBCUTANEOUS

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1